In a heartbreaking plea, Nigerian cancer survivors have called on the Federal Government to take urgent action to protect patients from the growing menace of counterfeit drugs. The survivors, many of whom have battled the disease for years, shared their harrowing experiences with fake medications, urging authorities to prioritize their safety and well-being.
"We have fought so hard to overcome cancer, only to face the devastating consequences of fake drugs," said Amina Suleiman, a breast cancer survivor. "It's a nightmare we wouldn't wish on our worst enemies. The government must act now to save lives and ensure we have access to genuine, life-saving treatments."
The survivors' plea comes on the heels of a recent case in Delhi, India, where a counterfeit cancer drug operation was uncovered, leading to the arrest of 12 suspects. The chargesheet revealed that eight patients who consumed the fake medications were identified during the investigation, with one fatality.
"The Delhi case is a stark reminder of the real dangers posed by counterfeit drugs," said Dr. Fatima Adamu, an oncologist at the National Hospital, Abuja. "Fake medications not only fail to treat the disease but can also cause serious harm or even death. We must take action to prevent such tragedies from occurring in Nigeria."
The survivors have called on the National Agency for Food and Drug Administration and Control (NAFDAC) to strengthen its efforts in combating the influx of counterfeit drugs into the country. They have also urged the government to invest in public awareness campaigns to educate patients on the risks of purchasing medications from unregulated sources.
"Cancer patients are already fighting for their lives; they shouldn't have to worry about the authenticity of their treatments," said Chidi Nwoke, a survivor of prostate cancer. "We need the government to prioritize our safety and ensure that every Nigerian has access to genuine, high-quality medicines."
The survivors have vowed to continue advocating for change until the government takes decisive action to address the issue of counterfeit drugs. They have called on all stakeholders, including healthcare professionals, pharmaceutical companies, and law enforcement agencies, to work together to eradicate this deadly menace.